ArticleJournal of orthopaedic surgery and research2026
Arthroscopic transglenoid dynamic subscapular sling achieves short-term clinical outcomes in patients with recurrent shoulder dislocation.
Article in Journal of orthopaedic surgery and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeThis study evaluated short-term outcomes of arthroscopic transglenoid dynamic subscapular sling (ATDSS) for recurrent anterior shoulder instability (RASI) with < 20% glenoid bone loss (GBL).
methodsA retrospective series of 25 patients (mean age 36.4 ± 17.3 years) undergoing ATDSS using an adjustable-length loop cortical suspensory fixation device with a tendon graft (semitendinosus autograft, palmaris longus autograft, or tibialis anterior allograft) around the upper subscapularis tendon was analyzed. Outcomes included Oxford Shoulder Instability Score (OSIS), visual analogue scale (VAS), Rowe score, American Shoulder and Elbow Surgeons (ASES) score, recurrence, sports activity, and range of motion at ≥ 12-month follow-up.
resultsAt mean 20.6 ± 4.9 months, significant improvements were observed: Rowe score (31.2 ± 16.7 vs. 83.0 ± 15.6, P < 0.001; Hedges' g = 3.21), OSIS (33.4 ± 8.0 vs. 20.2 ± 7.9, P < 0.001), ASES (81.6 ± 2.2 vs. 94.3 ± 4.5, P < 0.001), and VAS pain (1.2 ± 0.6 vs. 0.5 ± 0.6, P < 0.001). External rotation decreased (65.6° ± 6.8° vs. 56.5° ± 8.0°, P < 0.001), but only 24% exceeded the 10° minimal clinically important difference. Forward flexion remained unchanged (160.9° ± 15.1° vs. 160.1° ± 14.5°, P = 0.329). Recurrence occurred in 1 patient (4%), with no infections or complications. Sports activity improved (P < 0.001): 48% (12/25) achieved full premorbid activity (Grade I) versus 4% preoperatively.
conclusionATDSS using an adjustable-loop cortical suspensory device effectively stabilizes RASI with < 20% GBL, yielding low recurrence (4%), significant functional gains (Rowe, ASES, OSIS), and pain reduction. Minor external rotation loss did not impair function. The technique minimizes subscapularis dissection, avoids hardware complications, and preserves anatomy, offering a minimally invasive solution for subcritical GBL. LEVEL OF EVIDENCE: Level IV; Case Series; retrospective study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.